Gráfico del Precio de Acciones QNRX
QNRX Ganando
Quoin Pharmaceuticals Ltd
$5.46
-4.21%
$-0.24
Al cierre: Apr 27, 16:00:00 GMT-4
$5.45
-0.18%
$0
Mercado Previo: Apr 28, 09:17:24 GMT-4
Atrás
Quoin Pharmaceuticals Ltd (QNRX) Ganando
Estadísticas clave
Cierre Anterior
$5.7
Precio de apertura
$5.82
Rango del día
$5.43 - $5.86
Rango de 52 semanas
$5.01 - $41.8
Volumen
11.3K
Volumen promedio
101.6K
Rendimiento de dividendos
--
EPS (TTM)
-19.85
Cap. de mercado
$9.8M
¿Qué es QNRX?
Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. The Company’s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology, to treat Netherton Syndrome. The product going to be developed for other rare dermatological diseases including Peeling Skin Syndrome, SAM Syndrome, and Palmoplantar Keratoderma. Quoin is also developing QRX004 as a potential treatment for Dystrophic Epidermolysis Bullosa, and QRX006 as a potential therapy for an, as of yet, undisclosed rare skin disease.
Características
Recursos
© 2026 Finture Development Limited. Todos los derechos reservados.